ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 98 filers reported holding ABEONA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $269,000 | -41.6% | 88,629 | -96.0% | 0.16% | -40.3% |
Q2 2022 | $461,000 | -35.0% | 2,215,740 | 0.0% | 0.26% | -40.9% |
Q1 2022 | $709,000 | +8.9% | 2,215,740 | 0.0% | 0.44% | +24.3% |
Q4 2021 | $651,000 | -79.7% | 2,215,740 | -22.5% | 0.36% | -77.6% |
Q3 2021 | $3,203,000 | -28.2% | 2,859,767 | 0.0% | 1.60% | -31.5% |
Q2 2021 | $4,461,000 | -17.0% | 2,859,767 | 0.0% | 2.33% | -33.5% |
Q1 2021 | $5,376,000 | +19.7% | 2,859,767 | 0.0% | 3.50% | +14.4% |
Q4 2020 | $4,490,000 | +53.9% | 2,859,767 | 0.0% | 3.06% | +28.1% |
Q3 2020 | $2,917,000 | -64.2% | 2,859,767 | 0.0% | 2.39% | -49.2% |
Q2 2020 | $8,150,000 | +35.7% | 2,859,767 | 0.0% | 4.70% | -16.6% |
Q1 2020 | $6,006,000 | -35.8% | 2,859,767 | 0.0% | 5.64% | -18.3% |
Q4 2019 | $9,351,000 | +75.3% | 2,859,767 | +21.2% | 6.90% | +41.5% |
Q3 2019 | $5,333,000 | -52.7% | 2,359,767 | 0.0% | 4.88% | -47.1% |
Q2 2019 | $11,280,000 | -35.1% | 2,359,767 | 0.0% | 9.23% | -30.0% |
Q1 2019 | $17,368,000 | +3.1% | 2,359,767 | 0.0% | 13.20% | -31.1% |
Q4 2018 | $16,849,000 | -43.2% | 2,359,767 | 0.0% | 19.17% | -23.5% |
Q3 2018 | $29,639,000 | -21.5% | 2,359,767 | 0.0% | 25.06% | -21.9% |
Q2 2018 | $37,756,000 | +11.5% | 2,359,767 | 0.0% | 32.08% | -7.7% |
Q1 2018 | $33,863,000 | -9.5% | 2,359,767 | 0.0% | 34.77% | +5.4% |
Q4 2017 | $37,402,000 | -7.0% | 2,359,767 | 0.0% | 32.97% | -4.2% |
Q3 2017 | $40,234,000 | +166.4% | 2,359,767 | 0.0% | 34.40% | +71.8% |
Q2 2017 | $15,103,000 | +28.6% | 2,359,767 | 0.0% | 20.02% | +13.1% |
Q1 2017 | $11,740,000 | +2.6% | 2,359,767 | 0.0% | 17.70% | -11.9% |
Q4 2016 | $11,445,000 | +42.4% | 2,359,767 | +73.5% | 20.08% | +42.5% |
Q3 2016 | $8,036,000 | +150.4% | 1,359,767 | 0.0% | 14.09% | +1254.9% |
Q2 2016 | $3,209,000 | -7.8% | 1,359,767 | 0.0% | 1.04% | -26.4% |
Q1 2016 | $3,481,000 | -23.8% | 1,359,767 | 0.0% | 1.41% | -16.6% |
Q4 2015 | $4,569,000 | -17.0% | 1,359,767 | 0.0% | 1.69% | -27.5% |
Q3 2015 | $5,507,000 | -20.0% | 1,359,767 | 0.0% | 2.34% | +5.4% |
Q2 2015 | $6,880,000 | – | 1,359,767 | – | 2.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,359,767 | $37,402,000 | 32.97% |
Kavi Asset Management, LP | 214,600 | $3,401,000 | 2.35% |
Cormorant Asset Management, LP | 575,000 | $9,114,000 | 0.95% |
Castle Hook Partners LP | 1,190,100 | $18,863,000 | 0.94% |
EAM Investors, LLC | 167,015 | $2,647,000 | 0.47% |
EAM Global Investors LLC | 54,160 | $858,000 | 0.44% |
Virtus ETF Advisers LLC | 21,840 | $346,000 | 0.43% |
VIKING GLOBAL INVESTORS LP | 4,040,727 | $64,046,000 | 0.39% |
SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $3,329,000 | 0.39% |
Baker Brothers Advisors | 1,984,364 | $31,452,000 | 0.27% |